Ramoil Management, Ltd on Tuesday announced that RAMO Bio-Med, Inc., its wholly owned subsidiary, has now completed the R&D, printing and packaging and has begun the initial product rollout of "RAMO CBD Pain" product line, utilizing proprietary formulas and a proprietary high CBD, extremely low THC cannabis strain, through Natural Elements Group, Inc. in California.
Further, RAMO Bio-Med, Inc. also consulted with Natural Elements Group, Inc. to formulate their own THC product line as well, the company announced.
RAMO Bio-Med, Inc. is presently ramping up production and said it will soon be able to ship its proprietary "RAMO CBD Pain" formula to all 50 states as well as internationally. As for THC, RAMO Bio-Med, Inc. will act as a consultant and formulator in each state to assist local state licensed growers to develop their own private label THC lines and brands for their respective state markets.
"Ramoil Management and RAMO Bio-Med are now open for business!," said Michael Goeree, Ramoil Management's chairman, president and CEO.
About Ramoil Management, Ltd.
Ramoil Management, Ltd. (RAMO) is a development stage company. The company is an online wholesaler of e-cigarettes containing nutraceutical vapor oils, e-cigarette delivery systems and hydroponic lighting and nutrients.